BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Davis J, Chun AK, Borum ML. Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World J Hepatol 2016; 8(19): 790-795 [PMID: 27429715 DOI: 10.4254/wjh.v8.i19.790]
URL: https://www.wjgnet.com/1948-5182/full/v8/i19/790.htm
Number Citing Articles
1
Lucas H. P. Bernts, Joost P. H. Drenth, Eric T. T. L. Tjwa. Management of portal hypertension and ascites in polycystic liver diseaseLiver International 2019; 39(11): 2024 doi: 10.1111/liv.14245
2
Ishan Sinha, Daryl T. Goldman, Rahul S. Patel, Francis S. Nowakowski. Endovascular Alternatives to Transhepatic Shunt CreationSeminars in Interventional Radiology 2023; 40(01): 073 doi: 10.1055/s-0043-1767687
3
Ja Kyung Yoon, Man-Deuk Kim, Do Yun Lee, Seok Joo Han. Mesocaval Shunt Creation for Jejunal Variceal Bleeding with Chronic Portal Vein ThrombosisYonsei Medical Journal 2018; 59(1): 162 doi: 10.3349/ymj.2018.59.1.162
4
Yashwant Patidar, Sushant Babbar, Amar Mukund, Shiv Kumar Sarin. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Extension for Transhepatic Mesocaval Shunt Creation: A Case Series for Treating Refractory Upper Gastrointestinal Bleeding in Patients with Chronic Portal Vein ThrombosisIndian Journal of Radiology and Imaging 2024; 34(02): 335 doi: 10.1055/s-0043-1777321
5
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer PatientsCurrent Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
6
Indrani Sen, Lavanya Yohanathan, Jussi M. Kärkkäinen, David M. Nagorney. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in AdultsJournal of Gastrointestinal Surgery 2021; 25(6): 1437 doi: 10.1007/s11605-020-04643-1